• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Clinical practice guidelines linked to improved bronchiolitis outcomes

byNeha JoshiandLeah Carr, MD
February 17, 2014
in Infectious Disease, Pediatrics, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Implementation of an institution-specific clinical practice guideline for patients hospitalized with bronchiolitis showed reduction in usage of bronchodilators, steroids, and chest radiographs. No changes in antibiotic use were seen.

2. Average length of stay for bronchiolitis patients decreased, though readmission rates remained similar before and after guideline implementation.

Evidence Rating Level: 2 (Good)

Study Rundown: Bronchiolitis is a common cause of pediatric admissions during winter months. Evidence-based treatment for bronchiolitis includes supportive care, with bronchodilator use reserved for patients with a reactive airway component to their disease. However, clinical practice greatly varies and may include use of chest radiographs in diagnosis and the additional administration of antibiotics and/or steroids. The American Academy of Pediatrics (AAP) published a clinical practice guideline (CPG) in 2006 to help address such discrepancies and promote value-conscious and evidence-based care. This quality report examined the effects of an institution-specific CPG based on national guidelines. With a multifaceted implementation strategy including provider education, electronic order sets, and objective symptom measurement tools, improvement in outcomes was noted. A sustained decrease in use of bronchodilators, steroids, and chest radiographs was seen over the 2-year study period compared to pre-implementation data. Additionally, a significant decrease in length of stay (LOS) without changes in readmission data was observed. No changes in antibiotic use were seen. Though this CPG is institution-specific, it suggests quality improvement methods can promote value-conscious care alongside better outcomes for bronchiolitis.

Click to read the study published today in Pediatrics

RELATED REPORTS

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

Relevant Reading: AAP: Diagnosis and Management of Bronchiolitis

Study Author, Dr. Vineeta Mittal, MD, talks to 2 Minute Medicine: Department of Pediatrics, University of Texas Southwestern Medical Center and Children’s Medical Center, Dallas, Texas.

“Through collaborative teamwork we were able to streamline care and reduce unnecessary tests and treatments. Implementing evidence based clinical practice guidelines might be a good way for hospitals to provide value-based care.”

In-Depth [quality improvement]: This multidisciplinary quality improvement project included the development of an institution-specific CPG at a tertiary children’s hospital in Texas. Patient records for children age < 2 years diagnosed with bronchiolitis were obtained from 3 years of bronchiolitis season (September – April) – 1 pre-implementation year (1244 patients), and 2 post-implementation years (1159 patients, 1283 patients). Main drivers included multidisciplinary provider education, electronic order sets with inclusion of CPG measures, and objective measurements for certain parameters. As certain bronchiolitis patients respond to bronchodilators, the CPG metric allowed for trial of inhaled epinephrine or albuterol with response quantification with the Respiratory Distress Assessment Index. Significant decreases were noted in use of bronchodilators (27% to 14%, P = 0.002), steroids (19% to 11%, P = 0.018), and chest radiographs (60% to 39%, P = 0.001). Changes in antibiotic usage (37% to 25%, P = 0.16) were not significant. Average LOS decreased from 2.3 to 1.9 days, though readmission rate (2.3% to 1.8%, P = 0.45) remained similar.

More from this author: Dexamethasone shows comparable efficacy to prednisone/prednisolone in pediatric asthma, Cardiovascular events in Kawasaki disease not significantly increased over controls, Hypotonic IVF linked to increased risk of hyponatremia, New risk stratification algorithm suggested for neonatal sepsis, Decreased trainee autonomy suggested with in-hospital intensivist coverage

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 


Tags: bronchiolitisclinical practice guidelineRSV
Previous Post

2 Minute Medicine Rewind February 10-16, 2014

Next Post

Bullying associated with poorer health among middle school children

RelatedReports

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Pharma

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

February 24, 2025
Clinical practice guidelines linked to improved bronchiolitis outcomes
Infectious Disease

Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants

October 11, 2024
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
StudyGraphics

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

October 7, 2024
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
StudyGraphics

#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis

July 22, 2024
Next Post
Bullying associated with poorer health among middle school children

Bullying associated with poorer health among middle school children

Soaring rates of peripheral artery disease, now over 200 million cases worldwide

Intracranial carotid artery atherosclerosis independently linked to increased stroke risk

Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial

Rituximab not beneficial long-term in Sjorgen’s Syndrome

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • TikTok’s cortisol face trend meets endocrine reality
  • Semaglutide (Ozempic) raises questions about mood and nonresponse
  • Cruise ship hantavirus outbreak turns into a global contact tracing test
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.